Hadulla-Lazica, B. (1981). DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin): Nebenwirkungen bei der Behandlung maligner Melanome.
Chicago Style (17th ed.) CitationHadulla-Lazica, Barbara. DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin): Nebenwirkungen Bei Der Behandlung Maligner Melanome. 1981.
MLA (9th ed.) CitationHadulla-Lazica, Barbara. DTIC (Dimethyl-Triazeno-Imidazol-Carboxamid)-Dome (Dacarbacin): Nebenwirkungen Bei Der Behandlung Maligner Melanome. 1981.
Warning: These citations may not always be 100% accurate.